General Information of the Compound
Compound ID
CP0376249
Compound Name
2-Morpholin-4-yl-benzo[h]chromene-4-thione
    Show/Hide
Synonyms
2-Morpholin-4-yl-benzo[h]chromene-4-thione
CHEMBL176233
SCHEMBL13346492
    Show/Hide
Structure
Formula
C17H15NO2S
Molecular Weight
297.379
Canonical SMILES
S=c1cc(oc2c3ccccc3ccc12)N1CCOCC1
    Show/Hide
InChI
InChI=1S/C17H15NO2S/c21-15-11-16(18-7-9-19-10-8-18)20-17-13-4-2-1-3-12(13)5-6-14(15)17/h1-6,11H,7-10H2
    Show/Hide
InChIKey
VNZKDSHSVFSENH-UHFFFAOYSA-N
Physicochemical Property
logP
4.15209
Rotatable Bonds
1
Heavy Atom Count
21
Polar Areas
25.61
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11426483
SID: 16523697
ChEMBL ID
CHEMBL176233
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00955, DNA-dependent protein kinase catalytic subunit
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 260 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( 2-Morpholin-4-yl-benzo[h]chromene-4-thione )
Drug Name 2-Morpholin-4-yl-benzo[h]chromene-4-thione
Target(s)
DNA-dependent protein kinase catalytic (PRKDC)
Inhibitor